Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Abstract Background Digoxin is a widely prescribed drug for congestive heart failure and atrial fibrillation. Digoxin has a narrow therapeutic index and toxicity can develop quite easily. Digoxin immune fab (DIF) is an effective treatment for toxicity, however there are limited studies characterizin...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Adis, Springer Healthcare
2024-06-01
|
| Cyfres: | Drugs - Real World Outcomes |
| Mynediad Ar-lein: | https://doi.org/10.1007/s40801-024-00435-0 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|